New biomedical technologies are on the cusp of dramatically impacting not only healthcare and how we treat disease, but life itself. Visionary biologist, Andrew Hessel, spoke at our May What’s Now: San Francisco session exploring the extraordinary potential—and potential drawbacks—of gene editing and 3D printing in the field of biotech.
Related Resources
Capgemini lauded as a Market Leader in Next-gen ADM by ISG – three years running
Business-focused ADM that wins among thought leaders and clients alike
Exploring new revenue opportunities in 5G
5G networks offer more bandwidth, better latency, and improved reliability. Those...